Characterisation of CTX-M and AmpC genes in human isolates of Escherichia coli identified between 1995 and 2003 in England and Wales
- K. L. Hopkins(corresponding author),
- M. J. Batchelor,
- E. Liebana,
- A. P. Deheer-Graham,
- E. J. Threlfall
- ,
- Health Protection Agency,
- Animal and Plant Health Agency
Abstract
CTX-M and AmpC genes in human isolates of Escherichia coli, their genetic environment and their host plasmids were examined. Isolates (n = 103) were selected based on resistance (minimum inhibitory concentration (MIC) ≥ 1 μg/mL) to ceftriaxone and cefotaxime. Polymerase chain reaction (PCR) and sequencing identified 29 isolates containing blaCTX-M-15, 1 each of blaCTX-M-2 (a strain originating from Israel) and blaCTX-M-40, 20 isolates containing blaCMY-7, 4 blaCMY-2 and 1 blaCMY-21. This is the first study of plasmid-mediated AmpC genes in E. coli in the UK. Eleven cefoxitin-resistant, AmpC PCR-negative isolates had ampC promoter region mutations. All blaCTX-M-15 and 24 of 25 blaCMY genes were associated with an ISEcp1-like element. The blaCTX-M-2 was located in an orf513-bearing class 1 integron. Plasmid restriction digests suggest transfer of genes between different plasmid backbones.
Research Output Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 180-192 (13 pages)Journal (Volume, Issue Number)
International Journal of Antimicrobial Agents (Volume 28, Issue 3)Publication milestones
- Published - 09/2006
Publication status
ISSN
0924-8579Publication IDs
- Scopus: 33747135849
- PubMed: 16879949
Funding Details
Sustainable Development Goals
- SDG 3 Good Health and Well
